The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data.

Published in: Dermatologic therapy (2019)

A rapid and continual improvement in QoL was obtained with omalizumab treatment. A better UAS7, UCT, DLQI, and CU-Q2oL score at the baseline might be a predictor of a better response to omalizumab and more improvement in QoL.

Keyphrases

electronic health record
big data
machine learning
deep learning
quantum dots
smoking cessation